Population
Pituitary (AtT20) and cardiac (HL-1) cell lines expressing GIRK channels
Comparison
Compound library of Na and K channel modulators… vs Control (and known inhibitors Ba and tertiapin-Q)
Design
Preclinical
Authors
Loading...
May support GIRK-targeted arrhythmia therapies; leaves open translation from animal screening to clinical use.
A novel fluorescent screening assay successfully identified new GIRK channel blockers, providing a tool for developing therapeutic agents for GIRK channelopathies such as cardiac arrhythmias.
Kenneth B. Walsh (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: